Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Letsch

Showing results (71-80 of 83) with videos related to

Pageof 9
Sort By:
Annals of Hematology|April 5, 2017
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trialFriederike Braulke, Xenia Schulz, Ulrich Germing, et al.
Journal of Medical Genetics|June 11, 2017
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNAJohann-Christoph Jann, Daniel Nowak, Florian Nolte, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2025
Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study)Melisa Guelhan Inci, Ebru Ilter, Eva Roser, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 13, 2025
The Prognostic Role of Frailty and Its Recognition With Simple FRAIL and Fried Frailty Questionnaires in Advanced Cancer PatientsPia Weinländer, Sara Hadzibegovic, Jan Porthun, et al.
Annals of Hematology|April 27, 2021
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)Anna Hecht, Julia A Meyer, Johann-Christoph Jann, et al.
Geburtshilfe Und Frauenheilkunde|November 5, 2019
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)Hans-Georg Schnürch, Sven Ackermann, Celine D Alt-Radtke, et al.
Journal of Cancer Research and Clinical Oncology|May 5, 2023
Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa projectFriederike Braulke, Servet Para, Bernd Alt-Epping, et al.
Geburtshilfe Und Frauenheilkunde|February 24, 2022
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare FacilitiesTanja Fehm, Frederik A Stübs, Martin C Koch, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and TherapyMatthias W Beckmann, Frederik A Stübs, Martin C Koch, et al.
Geburtshilfe Und Frauenheilkunde|August 17, 2023
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply StructuresGünter Emons, Eric Steiner, Dirk Vordermark, et al.
Pageof 9

Showing results (71-80 of 83) with videos related to

Sort By:
Pageof 9
Annals of Hematology|April 5, 2017
Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trialFriederike Braulke, Xenia Schulz, Ulrich Germing, et al.
Journal of Medical Genetics|June 11, 2017
Accurate quantification of chromosomal lesions via short tandem repeat analysis using minimal amounts of DNAJohann-Christoph Jann, Daniel Nowak, Florian Nolte, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 13, 2025
Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study)Melisa Guelhan Inci, Ebru Ilter, Eva Roser, et al.
Journal of Cachexia, Sarcopenia and Muscle|October 13, 2025
The Prognostic Role of Frailty and Its Recognition With Simple FRAIL and Fried Frailty Questionnaires in Advanced Cancer PatientsPia Weinländer, Sara Hadzibegovic, Jan Porthun, et al.
Annals of Hematology|April 27, 2021
Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)Anna Hecht, Julia A Meyer, Johann-Christoph Jann, et al.
Geburtshilfe Und Frauenheilkunde|November 5, 2019
Diagnosis, Therapy and Follow-up of Vaginal Cancer and Its Precursors. Guideline of the DGGG and the DKG (S2k-Level, AWMF Registry No. 032/042, October 2018)Hans-Georg Schnürch, Sven Ackermann, Celine D Alt-Radtke, et al.
Journal of Cancer Research and Clinical Oncology|May 5, 2023
Systematic symptom screening in patients with advanced cancer treated in certified oncology centers: results of the prospective multicenter German KeSBa projectFriederike Braulke, Servet Para, Bernd Alt-Epping, et al.
Geburtshilfe Und Frauenheilkunde|February 24, 2022
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 2 with Recommendations on Psycho-oncology, Rehabilitation, Follow-up, Recurrence, Palliative Therapy and Healthcare FacilitiesTanja Fehm, Frederik A Stübs, Martin C Koch, et al.
Geburtshilfe Und Frauenheilkunde|February 16, 2022
Diagnosis, Therapy and Follow-up of Cervical Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry No. 032/033OL, May 2021) - Part 1 with Recommendations on Epidemiology, Screening, Diagnostics and TherapyMatthias W Beckmann, Frederik A Stübs, Martin C Koch, et al.
Geburtshilfe Und Frauenheilkunde|August 17, 2023
Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply StructuresGünter Emons, Eric Steiner, Dirk Vordermark, et al.
Pageof 9